APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sunitinib Malate

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Sunitinib Malate Market Analysis and Forecast 2026-2032

26 December 2025190 pages

Choose your research edition.

Industry ResearchSunitinib Malate Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Sunitinib Malate Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Sunitinib Malate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sunitinib Malate Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Sunitinib Malate Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Sunitinib Malate market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Sunitinib Malate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Sunitinib Malate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Sunitinib Malate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Sunitinib Malate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Sunitinib Malate include CSPC, Qilu Pharmaceutical, Nanjing First Pharmaceutical Co., Ltd., Hansoh Pharma, Pfizer Sutent, Topcare pharmaceutical Co., Ltd, Target Molecule Corp. and J&K Scientific, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Sunitinib Malate, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Sunitinib Malate, also provides the sales of main regions and countries. Of the upcoming market potential for Sunitinib Malate, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sunitinib Malate sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Sunitinib Malate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Sunitinib Malate sales, projected growth trends, production technology, application and end-user industry.

Sunitinib Malate Segment by Company

CSPC

Qilu Pharmaceutical

Nanjing First Pharmaceutical Co., Ltd.

Hansoh Pharma

Pfizer Sutent

Topcare pharmaceutical Co., Ltd

Target Molecule Corp.

J&K Scientific

Sunitinib Malate Segment by Type

12.5mg

37.5mg

50mg

Sunitinib Malate Segment by Application

Advanced Kidney Cancer

GIST (Gastrointestinal Stromal Tumor)

Pancreatic Neuroendocrine Tumors

Sunitinib Malate Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sunitinib Malate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sunitinib Malate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sunitinib Malate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Sunitinib Malate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Sunitinib Malate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sunitinib Malate sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Sunitinib Malate Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 12.5mg Major Manufacturers Table 3. 37.5mg Major Manufacturers Table 4. 50mg Major Manufacturers Table 5. Global Sunitinib Malate Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Advanced Kidney Cancer Major Manufacturers Table 7. GIST (Gastrointestinal Stromal Tumor) Major Manufacturers Table 8. Pancreatic Neuroendocrine Tumors Major Manufacturers Table 9. Sunitinib Malate Industry Trends Table 10. Sunitinib Malate Industry Drivers Table 11. Sunitinib Malate Industry Opportunities and Challenges Table 12. Sunitinib Malate Industry Restraints Table 13. Global Sunitinib Malate Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Sunitinib Malate Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Sunitinib Malate Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Sunitinib Malate Revenue Market Share by Region (2021-2026) Table 17. Global Sunitinib Malate Revenue Market Share by Region (2027-2032) Table 18. Global Sunitinib Malate Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (Units) Table 19. Global Sunitinib Malate Sales by Region (2021-2026) & (Units) Table 20. Global Sunitinib Malate Sales by Region (2027-2032) & (Units) Table 21. Global Sunitinib Malate Sales Market Share by Region (2021-2026) Table 22. Global Sunitinib Malate Sales Market Share by Region (2027-2032) Table 23. Global Sunitinib Malate Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Sunitinib Malate Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Sunitinib Malate Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Sunitinib Malate Sales Market Share by Manufacturers (2021-2026) Table 27. Global Sunitinib Malate Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Sunitinib Malate Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Sunitinib Malate Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Sunitinib Malate Manufacturers, Product Type & Application Table 31. Global Sunitinib Malate Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Sunitinib Malate by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Sunitinib Malate Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Sunitinib Malate Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Sunitinib Malate Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Sunitinib Malate Revenue Market Share by Type (2021-2026) Table 38. Global Sunitinib Malate Revenue Market Share by Type (2027-2032) Table 39. Global Sunitinib Malate Sales by Type 2021 VS 2025 VS 2032 (Units) Table 40. Global Sunitinib Malate Sales by Type (2021-2026) & (Units) Table 41. Global Sunitinib Malate Sales by Type (2027-2032) & (Units) Table 42. Global Sunitinib Malate Sales Market Share by Type (2021-2026) Table 43. Global Sunitinib Malate Sales Market Share by Type (2027-2032) Table 44. Global Sunitinib Malate Price by Type (2021-2026) & (US$/Unit) Table 45. Global Sunitinib Malate Price by Type (2027-2032) & (US$/Unit) Table 46. Global Sunitinib Malate Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Sunitinib Malate Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Sunitinib Malate Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Sunitinib Malate Revenue Market Share by Application (2021-2026) Table 50. Global Sunitinib Malate Revenue Market Share by Application (2027-2032) Table 51. Global Sunitinib Malate Sales by Application 2021 VS 2025 VS 2032 (Units) Table 52. Global Sunitinib Malate Sales by Application (2021-2026) & (Units) Table 53. Global Sunitinib Malate Sales by Application (2027-2032) & (Units) Table 54. Global Sunitinib Malate Sales Market Share by Application (2021-2026) Table 55. Global Sunitinib Malate Sales Market Share by Application (2027-2032) Table 56. Global Sunitinib Malate Price by Application (2021-2026) & (US$/Unit) Table 57. Global Sunitinib Malate Price by Application (2027-2032) & (US$/Unit) Table 58. CSPC Company Information Table 59. CSPC Business Overview Table 60. CSPC Sunitinib Malate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. CSPC Sunitinib Malate Product Portfolio Table 62. CSPC Recent Development Table 63. Qilu Pharmaceutical Company Information Table 64. Qilu Pharmaceutical Business Overview Table 65. Qilu Pharmaceutical Sunitinib Malate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Qilu Pharmaceutical Sunitinib Malate Product Portfolio Table 67. Qilu Pharmaceutical Recent Development Table 68. Nanjing First Pharmaceutical Co., Ltd. Company Information Table 69. Nanjing First Pharmaceutical Co., Ltd. Business Overview Table 70. Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Product Portfolio Table 72. Nanjing First Pharmaceutical Co., Ltd. Recent Development Table 73. Hansoh Pharma Company Information Table 74. Hansoh Pharma Business Overview Table 75. Hansoh Pharma Sunitinib Malate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Hansoh Pharma Sunitinib Malate Product Portfolio Table 77. Hansoh Pharma Recent Development Table 78. Pfizer Sutent Company Information Table 79. Pfizer Sutent Business Overview Table 80. Pfizer Sutent Sunitinib Malate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Pfizer Sutent Sunitinib Malate Product Portfolio Table 82. Pfizer Sutent Recent Development Table 83. Topcare pharmaceutical Co., Ltd Company Information Table 84. Topcare pharmaceutical Co., Ltd Business Overview Table 85. Topcare pharmaceutical Co., Ltd Sunitinib Malate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Topcare pharmaceutical Co., Ltd Sunitinib Malate Product Portfolio Table 87. Topcare pharmaceutical Co., Ltd Recent Development Table 88. Target Molecule Corp. Company Information Table 89. Target Molecule Corp. Business Overview Table 90. Target Molecule Corp. Sunitinib Malate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Target Molecule Corp. Sunitinib Malate Product Portfolio Table 92. Target Molecule Corp. Recent Development Table 93. J&K Scientific Company Information Table 94. J&K Scientific Business Overview Table 95. J&K Scientific Sunitinib Malate Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. J&K Scientific Sunitinib Malate Product Portfolio Table 97. J&K Scientific Recent Development Table 98. North America Sunitinib Malate Revenue by Type (2021-2026) & (US$ Million) Table 99. North America Sunitinib Malate Revenue by Type (2027-2032) & (US$ Million) Table 100. North America Sunitinib Malate Sales by Type (2021-2026) & (Units) Table 101. North America Sunitinib Malate Sales by Type (2027-2032) & (Units) Table 102. North America Sunitinib Malate Sales Price by Type (2021-2026) & (US$/Unit) Table 103. North America Sunitinib Malate Sales Price by Type (2027-2032) & (US$/Unit) Table 104. North America Sunitinib Malate Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Sunitinib Malate Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Sunitinib Malate Sales by Application (2021-2026) & (Units) Table 107. North America Sunitinib Malate Sales by Application (2027-2032) & (Units) Table 108. North America Sunitinib Malate Sales Price by Application (2021-2026) & (US$/Unit) Table 109. North America Sunitinib Malate Sales Price by Application (2027-2032) & (US$/Unit) Table 110. North America Sunitinib Malate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America Sunitinib Malate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. North America Sunitinib Malate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. North America Sunitinib Malate Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 114. North America Sunitinib Malate Sales by Country (2021-2026) & (Units) Table 115. North America Sunitinib Malate Sales by Country (2027-2032) & (Units) Table 116. North America Sunitinib Malate Sales Price by Country (2021-2026) & (US$/Unit) Table 117. North America Sunitinib Malate Sales Price by Country (2027-2032) & (US$/Unit) Table 118. United States Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 119. Canada Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 120. Mexico Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 121. Europe Sunitinib Malate Revenue by Type (2021-2026) & (US$ Million) Table 122. Europe Sunitinib Malate Revenue by Type (2027-2032) & (US$ Million) Table 123. Europe Sunitinib Malate Sales by Type (2021-2026) & (Units) Table 124. Europe Sunitinib Malate Sales by Type (2027-2032) & (Units) Table 125. Europe Sunitinib Malate Sales Price by Type (2021-2026) & (US$/Unit) Table 126. Europe Sunitinib Malate Sales Price by Type (2027-2032) & (US$/Unit) Table 127. Europe Sunitinib Malate Revenue by Application (2021-2026) & (US$ Million) Table 128. Europe Sunitinib Malate Revenue by Application (2027-2032) & (US$ Million) Table 129. Europe Sunitinib Malate Sales by Application (2021-2026) & (Units) Table 130. Europe Sunitinib Malate Sales by Application (2027-2032) & (Units) Table 131. Europe Sunitinib Malate Sales Price by Application (2021-2026) & (US$/Unit) Table 132. Europe Sunitinib Malate Sales Price by Application (2027-2032) & (US$/Unit) Table 133. Europe Sunitinib Malate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 134. Europe Sunitinib Malate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 135. Europe Sunitinib Malate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 136. Europe Sunitinib Malate Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 137. Europe Sunitinib Malate Sales by Country (2021-2026) & (Units) Table 138. Europe Sunitinib Malate Sales by Country (2027-2032) & (Units) Table 139. Europe Sunitinib Malate Sales Price by Country (2021-2026) & (US$/Unit) Table 140. Europe Sunitinib Malate Sales Price by Country (2027-2032) & (US$/Unit) Table 141. Germany Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 142. France Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 143. U.K. Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 144. Italy Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 145. Russia Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 146. Spain Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 147. Netherlands Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 148. Switzerland Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 149. Sweden Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 150. Poland Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 151. China Sunitinib Malate Revenue by Type (2021-2026) & (US$ Million) Table 152. China Sunitinib Malate Revenue by Type (2027-2032) & (US$ Million) Table 153. China Sunitinib Malate Sales by Type (2021-2026) & (Units) Table 154. China Sunitinib Malate Sales by Type (2027-2032) & (Units) Table 155. China Sunitinib Malate Sales Price by Type (2021-2026) & (US$/Unit) Table 156. China Sunitinib Malate Sales Price by Type (2027-2032) & (US$/Unit) Table 157. China Sunitinib Malate Revenue by Application (2021-2026) & (US$ Million) Table 158. China Sunitinib Malate Revenue by Application (2027-2032) & (US$ Million) Table 159. China Sunitinib Malate Sales by Application (2021-2026) & (Units) Table 160. China Sunitinib Malate Sales by Application (2027-2032) & (Units) Table 161. China Sunitinib Malate Sales Price by Application (2021-2026) & (US$/Unit) Table 162. China Sunitinib Malate Sales Price by Application (2027-2032) & (US$/Unit) Table 163. Asia Sunitinib Malate Revenue by Type (2021-2026) & (US$ Million) Table 164. Asia Sunitinib Malate Revenue by Type (2027-2032) & (US$ Million) Table 165. Asia Sunitinib Malate Sales by Type (2021-2026) & (Units) Table 166. Asia Sunitinib Malate Sales by Type (2027-2032) & (Units) Table 167. Asia Sunitinib Malate Sales Price by Type (2021-2026) & (US$/Unit) Table 168. Asia Sunitinib Malate Sales Price by Type (2027-2032) & (US$/Unit) Table 169. Asia Sunitinib Malate Revenue by Application (2021-2026) & (US$ Million) Table 170. Asia Sunitinib Malate Revenue by Application (2027-2032) & (US$ Million) Table 171. Asia Sunitinib Malate Sales by Application (2021-2026) & (Units) Table 172. Asia Sunitinib Malate Sales by Application (2027-2032) & (Units) Table 173. Asia Sunitinib Malate Sales Price by Application (2021-2026) & (US$/Unit) Table 174. Asia Sunitinib Malate Sales Price by Application (2027-2032) & (US$/Unit) Table 175. Asia Sunitinib Malate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 176. Asia Sunitinib Malate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 177. Asia Sunitinib Malate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 178. Asia Sunitinib Malate Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 179. Asia Sunitinib Malate Sales by Country (2021-2026) & (Units) Table 180. Asia Sunitinib Malate Sales by Country (2027-2032) & (Units) Table 181. Asia Sunitinib Malate Sales Price by Country (2021-2026) & (US$/Unit) Table 182. Asia Sunitinib Malate Sales Price by Country (2027-2032) & (US$/Unit) Table 183. Japan Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 184. South Korea Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 185. India Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 186. Australia Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 187. Taiwan Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 188. Southeast Asia Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 189. SAMEA Sunitinib Malate Revenue by Type (2021-2026) & (US$ Million) Table 190. SAMEA Sunitinib Malate Revenue by Type (2027-2032) & (US$ Million) Table 191. SAMEA Sunitinib Malate Sales by Type (2021-2026) & (Units) Table 192. SAMEA Sunitinib Malate Sales by Type (2027-2032) & (Units) Table 193. SAMEA Sunitinib Malate Sales Price by Type (2021-2026) & (US$/Unit) Table 194. SAMEA Sunitinib Malate Sales Price by Type (2027-2032) & (US$/Unit) Table 195. SAMEA Sunitinib Malate Revenue by Application (2021-2026) & (US$ Million) Table 196. SAMEA Sunitinib Malate Revenue by Application (2027-2032) & (US$ Million) Table 197. SAMEA Sunitinib Malate Sales by Application (2021-2026) & (Units) Table 198. SAMEA Sunitinib Malate Sales by Application (2027-2032) & (Units) Table 199. SAMEA Sunitinib Malate Sales Price by Application (2021-2026) & (US$/Unit) Table 200. SAMEA Sunitinib Malate Sales Price by Application (2027-2032) & (US$/Unit) Table 201. SAMEA Sunitinib Malate Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 202. SAMEA Sunitinib Malate Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 203. SAMEA Sunitinib Malate Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 204. SAMEA Sunitinib Malate Sales by Country (2021 VS 2025 VS 2032) & (Units) Table 205. SAMEA Sunitinib Malate Sales by Country (2021-2026) & (Units) Table 206. SAMEA Sunitinib Malate Sales by Country (2027-2032) & (Units) Table 207. SAMEA Sunitinib Malate Sales Price by Country (2021-2026) & (US$/Unit) Table 208. SAMEA Sunitinib Malate Sales Price by Country (2027-2032) & (US$/Unit) Table 209. Brazil Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 210. Argentina Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 211. Chile Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 212. Colombia Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 213. Peru Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 214. Saudi Arabia Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 215. Israel Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 216. UAE Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 217. Turkey Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 218. Iran Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 219. Egypt Sunitinib Malate Revenue (2021-2032) & (US$ Million) Table 220. Key Raw Materials Table 221. Raw Materials Key Suppliers Table 222. Sunitinib Malate Distributors List Table 223. Sunitinib Malate Customers List Table 224. Research Programs/Design for This Report Table 225. Authors List of This Report Table 226. Secondary Sources Table 227. Primary Sources List of Figures Figure 1. Sunitinib Malate Image Figure 2. Global Sunitinib Malate Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sunitinib Malate Market Size Share 2021 VS 2025 VS 2032 Figure 4. 12.5mg Image Figure 5. 37.5mg Image Figure 6. 50mg Image Figure 7. Global Sunitinib Malate Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Sunitinib Malate Market Size Share 2021 VS 2025 VS 2032 Figure 9. Advanced Kidney Cancer Image Figure 10. GIST (Gastrointestinal Stromal Tumor) Image Figure 11. Pancreatic Neuroendocrine Tumors Image Figure 12. Global Sunitinib Malate Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Sunitinib Malate Revenue (2021-2032) & (US$ Million) Figure 14. Global Sunitinib Malate Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Sunitinib Malate Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Sunitinib Malate Revenue Market Share by Region (2021-2032) Figure 17. Global Sunitinib Malate Sales (2021-2032) & (Units) Figure 18. Global Sunitinib Malate Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 19. Global Sunitinib Malate Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Sunitinib Malate Sales YoY (2021-2032) & (Units) Figure 21. Europe Sunitinib Malate Sales YoY (2021-2032) & (Units) Figure 22. China Sunitinib Malate Sales YoY (2021-2032) & (Units) Figure 23. Asia (Excluding China) Sunitinib Malate Sales YoY (2021-2032) & (Units) Figure 24. South America, Middle East and Africa Sunitinib Malate Sales YoY (2021-2032) & (Units) Figure 25. Global Sunitinib Malate Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Sunitinib Malate Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Sunitinib Malate Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Sunitinib Malate Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Sunitinib Malate Revenue Market Share by Type (2021-2032) Figure 31. Global Sunitinib Malate Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 32. Global Sunitinib Malate Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Sunitinib Malate Sales Market Share by Type (2021-2032) Figure 34. Global Sunitinib Malate Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Sunitinib Malate Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Sunitinib Malate Revenue Market Share by Application (2021-2032) Figure 37. Global Sunitinib Malate Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 38. Global Sunitinib Malate Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Sunitinib Malate Sales Market Share by Application (2021-2032) Figure 40. North America Sunitinib Malate Revenue Share by Type (2021-2032) Figure 41. North America Sunitinib Malate Sales Share by Type (2021-2032) Figure 42. North America Sunitinib Malate Revenue Share by Application (2021-2032) Figure 43. North America Sunitinib Malate Sales Share by Application (2021-2032) Figure 44. North America Sunitinib Malate Revenue Share by Country (2021-2032) Figure 45. North America Sunitinib Malate Sales Share by Country (2021-2032) Figure 46. Europe Sunitinib Malate Revenue Share by Type (2021-2032) Figure 47. Europe Sunitinib Malate Sales Share by Type (2021-2032) Figure 48. Europe Sunitinib Malate Revenue Share by Application (2021-2032) Figure 49. Europe Sunitinib Malate Sales Share by Application (2021-2032) Figure 50. Europe Sunitinib Malate Revenue Share by Country (2021-2032) Figure 51. Europe Sunitinib Malate Sales Share by Country (2021-2032) Figure 52. China Sunitinib Malate Revenue Share by Type (2021-2032) Figure 53. China Sunitinib Malate Sales Share by Type (2021-2032) Figure 54. China Sunitinib Malate Revenue Share by Application (2021-2032) Figure 55. China Sunitinib Malate Sales Share by Application (2021-2032) Figure 56. Asia Sunitinib Malate Revenue Share by Type (2021-2032) Figure 57. Asia Sunitinib Malate Sales Share by Type (2021-2032) Figure 58. Asia Sunitinib Malate Revenue Share by Application (2021-2032) Figure 59. Asia Sunitinib Malate Sales Share by Application (2021-2032) Figure 60. Asia Sunitinib Malate Revenue Share by Country (2021-2032) Figure 61. Asia Sunitinib Malate Sales Share by Country (2021-2032) Figure 62. SAMEA Sunitinib Malate Revenue Share by Type (2021-2032) Figure 63. SAMEA Sunitinib Malate Sales Share by Type (2021-2032) Figure 64. SAMEA Sunitinib Malate Revenue Share by Application (2021-2032) Figure 65. SAMEA Sunitinib Malate Sales Share by Application (2021-2032) Figure 66. SAMEA Sunitinib Malate Revenue Share by Country (2021-2032) Figure 67. SAMEA Sunitinib Malate Sales Share by Country (2021-2032) Figure 68. Sunitinib Malate Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Sunitinib Malate Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 12.5mg
  • 37.5mg
  • 50mg
Applications
  • Advanced Kidney Cancer
  • GIST (Gastrointestinal Stromal Tumor)
  • Pancreatic Neuroendocrine Tumors
Companies covered
  • CSPC
  • Qilu Pharmaceutical
  • Nanjing First Pharmaceutical Co., Ltd.
  • Hansoh Pharma
  • Pfizer Sutent
  • Topcare pharmaceutical Co., Ltd
  • Target Molecule Corp.
  • J&K Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Sunitinib Malate Market by Type
  3. 1.2.1 Global Sunitinib Malate Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 12.5mg
  5. 1.2.3 37.5mg
  6. 1.2.4 50mg
  7. 1.3 Sunitinib Malate Market by Application
  8. 1.3.1 Global Sunitinib Malate Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Advanced Kidney Cancer
  10. 1.3.3 GIST (Gastrointestinal Stromal Tumor)
  11. 1.3.4 Pancreatic Neuroendocrine Tumors
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Sunitinib Malate Market Dynamics
  1. 2.1 Sunitinib Malate Industry Trends
  2. 2.2 Sunitinib Malate Industry Drivers
  3. 2.3 Sunitinib Malate Industry Opportunities and Challenges
  4. 2.4 Sunitinib Malate Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Sunitinib Malate Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Sunitinib Malate Revenue by Region
  3. 3.2.1 Global Sunitinib Malate Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Sunitinib Malate Revenue by Region (2021-2026)
  5. 3.2.3 Global Sunitinib Malate Revenue by Region (2027-2032)
  6. 3.2.4 Global Sunitinib Malate Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Sunitinib Malate Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Sunitinib Malate Sales by Region
  9. 3.4.1 Global Sunitinib Malate Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Sunitinib Malate Sales by Region (2021-2026)
  11. 3.4.3 Global Sunitinib Malate Sales by Region (2027-2032)
  12. 3.4.4 Global Sunitinib Malate Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Sunitinib Malate Revenue by Manufacturers
  2. 4.1.1 Global Sunitinib Malate Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Sunitinib Malate Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Sunitinib Malate Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Sunitinib Malate Sales by Manufacturers
  6. 4.2.1 Global Sunitinib Malate Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Sunitinib Malate Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Sunitinib Malate Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Sunitinib Malate Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Sunitinib Malate Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Sunitinib Malate Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Sunitinib Malate Manufacturers, Product Type & Application
  13. 4.7 Global Sunitinib Malate Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Sunitinib Malate Market CR5 and HHI
  16. 4.8.2 2025 Sunitinib Malate Tier 1, Tier 2, and Tier 3
5 Sunitinib Malate Market by Type
  1. 5.1 Global Sunitinib Malate Revenue by Type
  2. 5.1.1 Global Sunitinib Malate Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Sunitinib Malate Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Sunitinib Malate Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Sunitinib Malate Sales by Type
  6. 5.2.1 Global Sunitinib Malate Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sunitinib Malate Sales by Type (2021-2032) & (Units)
  8. 5.2.3 Global Sunitinib Malate Sales Market Share by Type (2021-2032)
  9. 5.3 Global Sunitinib Malate Price by Type
6 Sunitinib Malate Market by Application
  1. 6.1 Global Sunitinib Malate Revenue by Application
  2. 6.1.1 Global Sunitinib Malate Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Sunitinib Malate Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Sunitinib Malate Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Sunitinib Malate Sales by Application
  6. 6.2.1 Global Sunitinib Malate Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Sunitinib Malate Sales by Application (2021-2032) & (Units)
  8. 6.2.3 Global Sunitinib Malate Sales Market Share by Application (2021-2032)
  9. 6.3 Global Sunitinib Malate Price by Application
7 Company Profiles
  1. 7.1 CSPC
  2. 7.1.1 CSPC Company Information
  3. 7.1.2 CSPC Business Overview
  4. 7.1.3 CSPC Sunitinib Malate Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 CSPC Sunitinib Malate Product Portfolio
  6. 7.1.5 CSPC Recent Developments
  7. 7.2 Qilu Pharmaceutical
  8. 7.2.1 Qilu Pharmaceutical Company Information
  9. 7.2.2 Qilu Pharmaceutical Business Overview
  10. 7.2.3 Qilu Pharmaceutical Sunitinib Malate Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Qilu Pharmaceutical Sunitinib Malate Product Portfolio
  12. 7.2.5 Qilu Pharmaceutical Recent Developments
  13. 7.3 Nanjing First Pharmaceutical Co., Ltd.
  14. 7.3.1 Nanjing First Pharmaceutical Co., Ltd. Company Information
  15. 7.3.2 Nanjing First Pharmaceutical Co., Ltd. Business Overview
  16. 7.3.3 Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Nanjing First Pharmaceutical Co., Ltd. Sunitinib Malate Product Portfolio
  18. 7.3.5 Nanjing First Pharmaceutical Co., Ltd. Recent Developments
  19. 7.4 Hansoh Pharma
  20. 7.4.1 Hansoh Pharma Company Information
  21. 7.4.2 Hansoh Pharma Business Overview
  22. 7.4.3 Hansoh Pharma Sunitinib Malate Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Hansoh Pharma Sunitinib Malate Product Portfolio
  24. 7.4.5 Hansoh Pharma Recent Developments
  25. 7.5 Pfizer Sutent
  26. 7.5.1 Pfizer Sutent Company Information
  27. 7.5.2 Pfizer Sutent Business Overview
  28. 7.5.3 Pfizer Sutent Sunitinib Malate Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Pfizer Sutent Sunitinib Malate Product Portfolio
  30. 7.5.5 Pfizer Sutent Recent Developments
  31. 7.6 Topcare pharmaceutical Co., Ltd
  32. 7.6.1 Topcare pharmaceutical Co., Ltd Company Information
  33. 7.6.2 Topcare pharmaceutical Co., Ltd Business Overview
  34. 7.6.3 Topcare pharmaceutical Co., Ltd Sunitinib Malate Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Topcare pharmaceutical Co., Ltd Sunitinib Malate Product Portfolio
  36. 7.6.5 Topcare pharmaceutical Co., Ltd Recent Developments
  37. 7.7 Target Molecule Corp.
  38. 7.7.1 Target Molecule Corp. Company Information
  39. 7.7.2 Target Molecule Corp. Business Overview
  40. 7.7.3 Target Molecule Corp. Sunitinib Malate Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Target Molecule Corp. Sunitinib Malate Product Portfolio
  42. 7.7.5 Target Molecule Corp. Recent Developments
  43. 7.8 J&K Scientific
  44. 7.8.1 J&K Scientific Company Information
  45. 7.8.2 J&K Scientific Business Overview
  46. 7.8.3 J&K Scientific Sunitinib Malate Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 J&K Scientific Sunitinib Malate Product Portfolio
  48. 7.8.5 J&K Scientific Recent Developments
8 North America
  1. 8.1 North America Sunitinib Malate Market Size by Type
  2. 8.1.1 North America Sunitinib Malate Revenue by Type (2021-2032)
  3. 8.1.2 North America Sunitinib Malate Sales by Type (2021-2032)
  4. 8.1.3 North America Sunitinib Malate Price by Type (2021-2032)
  5. 8.2 North America Sunitinib Malate Market Size by Application
  6. 8.2.1 North America Sunitinib Malate Revenue by Application (2021-2032)
  7. 8.2.2 North America Sunitinib Malate Sales by Application (2021-2032)
  8. 8.2.3 North America Sunitinib Malate Price by Application (2021-2032)
  9. 8.3 North America Sunitinib Malate Market Size by Country
  10. 8.3.1 North America Sunitinib Malate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Sunitinib Malate Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Sunitinib Malate Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Sunitinib Malate Market Size by Type
  2. 9.1.1 Europe Sunitinib Malate Revenue by Type (2021-2032)
  3. 9.1.2 Europe Sunitinib Malate Sales by Type (2021-2032)
  4. 9.1.3 Europe Sunitinib Malate Price by Type (2021-2032)
  5. 9.2 Europe Sunitinib Malate Market Size by Application
  6. 9.2.1 Europe Sunitinib Malate Revenue by Application (2021-2032)
  7. 9.2.2 Europe Sunitinib Malate Sales by Application (2021-2032)
  8. 9.2.3 Europe Sunitinib Malate Price by Application (2021-2032)
  9. 9.3 Europe Sunitinib Malate Market Size by Country
  10. 9.3.1 Europe Sunitinib Malate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Sunitinib Malate Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Sunitinib Malate Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Sunitinib Malate Market Size by Type
  2. 10.1.1 China Sunitinib Malate Revenue by Type (2021-2032)
  3. 10.1.2 China Sunitinib Malate Sales by Type (2021-2032)
  4. 10.1.3 China Sunitinib Malate Price by Type (2021-2032)
  5. 10.2 China Sunitinib Malate Market Size by Application
  6. 10.2.1 China Sunitinib Malate Revenue by Application (2021-2032)
  7. 10.2.2 China Sunitinib Malate Sales by Application (2021-2032)
  8. 10.2.3 China Sunitinib Malate Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Sunitinib Malate Market Size by Type
  2. 11.1.1 Asia Sunitinib Malate Revenue by Type (2021-2032)
  3. 11.1.2 Asia Sunitinib Malate Sales by Type (2021-2032)
  4. 11.1.3 Asia Sunitinib Malate Price by Type (2021-2032)
  5. 11.2 Asia Sunitinib Malate Market Size by Application
  6. 11.2.1 Asia Sunitinib Malate Revenue by Application (2021-2032)
  7. 11.2.2 Asia Sunitinib Malate Sales by Application (2021-2032)
  8. 11.2.3 Asia Sunitinib Malate Price by Application (2021-2032)
  9. 11.3 Asia Sunitinib Malate Market Size by Country
  10. 11.3.1 Asia Sunitinib Malate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Sunitinib Malate Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Sunitinib Malate Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Sunitinib Malate Market Size by Type
  2. 12.1.1 SAMEA Sunitinib Malate Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Sunitinib Malate Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Sunitinib Malate Price by Type (2021-2032)
  5. 12.2 SAMEA Sunitinib Malate Market Size by Application
  6. 12.2.1 SAMEA Sunitinib Malate Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Sunitinib Malate Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Sunitinib Malate Price by Application (2021-2032)
  9. 12.3 SAMEA Sunitinib Malate Market Size by Country
  10. 12.3.1 SAMEA Sunitinib Malate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Sunitinib Malate Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Sunitinib Malate Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Sunitinib Malate Value Chain Analysis
  2. 13.1.1 Sunitinib Malate Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Sunitinib Malate Production Mode & Process
  6. 13.2 Sunitinib Malate Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Sunitinib Malate Distributors
  9. 13.2.3 Sunitinib Malate Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst